China Grand Pharmaceutical and Healthcare Holdings Limited logo

China Grand Pharmaceutical and Healthcare Holdings Limited (0512)

Market Open
11 Aug, 08:00
HKEX HKEX
5. 26
HKD
-0.13
-2.4119%
HKD
28.78B Market Cap
- P/E Ratio
1.04% Div Yield
4.2M Volume
- Eps
5.39 HKD
Previous Close
Add Transaction
Day Range
5.25 5.43
Year Range
4.53 9.88
Want to track 0512 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

China Grand Pharmaceutical and Healthcare Holdings Limited (0512) Statistics

Valuation metrics

Market Cap 28.78B
Enterprise value 21.89B
Trailing P/E (ttm) 14.94
Forward P/E 8.72
PEG ratio -0.3
Price/Sales (ttm) 1.49
Price/Book (mrq) 1.08
Enterprise Value/Revenue 1.78
Enterprise Value/EBITDA 9.48

Overview

Shares outstanding 3.5B
Float 1.26B
Shares short -
% Held by insiders 0.68%
% Held by institutions 0.17%
Average volume (10 days) 3.64M
Average volume (90 days) 5.52M

Price summary

52-Week low 4.53
52-Week high 9.88
Beta 0.74
50-Day moving average 5.09
200-Day moving average 6.25

Dividends and splits

Forward annual dividend rate 1.04
Forward annual dividend yield 0.1901%
Trailing annual dividend rate 0.17
Trailing annual dividend yield 0.0323%
5-Year annual dividend yield 3.22%
Payout ratio 0.73
Dividend Date 30 Jun 2026
Ex-Dividend Date 12 Jun 2026
Last split factor 519:500
Last split Date 6 Dec 2010

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025

Profitability

Profit margin 0.1%
Operating margin 0.08%

Operational effectiveness

Return on assets 0.05%
Return on equity 0.07%

Income Statement

Revenue (ttm) 12.28B
Revenue per share (ttm) 3.51
Quarterly revenue growth (yoy) 0.1%
Gross profit (ttm) 6.78B
EBITDA 2.45B
Net income to common (ttm) 1.24B
Diluted EPS (ttm) 0.35
Quarterly earnings growth (yoy) -0.92%

Balance Sheet

Total cash (mrq) 3.93B
Total cash per share (mrq) 0.6
Total debt (mrq) 4.72B
Total Debt/Equity (mrq) 0.28
Current ratio (mrq) 1.14%
Book value per share (mrq) 4.91

Cash Flow

Cash flow statement 1.65B
Levered free cash flow (LFCF) -47.05M